Clinical Trial: Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma
Sponsor and CollaboratorsDuke University
Celgene Corporation
ContactContact: Donna Adams, ANP
(919) 668-4716
adams068@mc.duke.edu
Contact: Patricia Davis, RN
(919) 668-1026
davis043@mc.duke.edu
Principal InvestigatorAnne W. Beaven, MD Duke University Medical Center Durham, NC USA
ClinicalTrials.gov IdentifierNCT01121757